Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Total Assets : ¥8,575 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Shenzhen New Industries Biomedical Engineering Co Total Assets?

Shenzhen New Industries Biomedical Engineering Co's Total Assets for the quarter that ended in Mar. 2024 was ¥8,575 Mil.

Warning Sign:

If a company builds assets at 34.2% a year, faster than its revenue growth rate of 19.5% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Shenzhen New Industries Biomedical Engineering Co's average Total Assets Growth Rate was 37.60% per year. During the past 3 years, the average Total Assets Growth Rate was 38.10% per year. During the past 5 years, the average Total Assets Growth Rate was 34.20% per year. During the past 10 years, the average Total Assets Growth Rate was 29.60% per year.

During the past 12 years, Shenzhen New Industries Biomedical Engineering Co's highest 3-Year average Total Assets Growth Rate was 61.50%. The lowest was 23.50%. And the median was 28.70%.

Total Assets is connected with ROA %. Shenzhen New Industries Biomedical Engineering Co's annualized ROA % for the quarter that ended in Mar. 2024 was 20.30%. Total Assets is also linked to Revenue through Asset Turnover. Shenzhen New Industries Biomedical Engineering Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.12.

Shenzhen New Industries Biomedical Engineering Co Total Assets Historical Data

The historical data trend for Shenzhen New Industries Biomedical Engineering Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen New Industries Biomedical Engineering Co Total Assets Chart

Shenzhen New Industries Biomedical Engineering Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

3,457.72

5,308.17

6,135.51

7,014.55

8,222.49

Shenzhen New Industries Biomedical Engineering Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															7,257.77	7,251.58	7,719.88	8,222.49	8,574.96

Shenzhen New Industries Biomedical Engineering Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Shenzhen New Industries Biomedical Engineering Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	7544.4	+	678.089
	=	8,222

Shenzhen New Industries Biomedical Engineering Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	7964.509	+	610.451
	=	8,575

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Total Assets Explanation

Total Assets is connected with ROA %.

Shenzhen New Industries Biomedical Engineering Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	1704.884	/	( (8222.489	+	8574.96)	/ 2 )
	=	1704.884	/	8398.7245
	=	20.30 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Shenzhen New Industries Biomedical Engineering Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	1021.43	/	( (8222.489	+	8574.96)	/ 2 )
=	1021.43	/	8398.7245
=	0.12

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Shenzhen New Industries Biomedical Engineering Co Total Assets Related Terms

Thank you for viewing the detailed overview of Shenzhen New Industries Biomedical Engineering Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen New Industries Biomedical Engineering Co Ltd (SZSE:300832) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 23, Jinxiu East Road, Kengzi Street, 21st Floor, New Industrial Bio Building, Jinsha Community, Pingshan District, Guangdong Province, Shenzhen, CHN, 518000

Website

http://www.snibe.com

Shenzhen New Industries Biomedical Engineering Co Ltd is a bio-medical company specialized in clinical laboratory instruments and in vitro diagnostic reagents. The company produces and sells series of automatic chemiluminescence immunoassay instruments and supporting reagents. Its products include Immunoassay, Clinical Chemistry, Integrated System, Lab Automation, and Reagents.

Executives

Ma Jie	Supervisors
Ding Chen Liu	Executives
Zhang Xiao Hong	Executives
Zhang Lei	Directors, executives
Li Ting Hua	Executives
Liu Hai Yan	Executives
Song Hong Tao	Supervisors
Liu Peng	Director
Jiang Li Li	Supervisors

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Headlines

No Headlines